PTO- 1581 |
Approved for use through 03/31/2024. OMB 0651-0054 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
PTO- 1581 |
Approved for use through 03/31/2024. OMB 0651-0054 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: HMC (see, http://uspto.report/TM/88070382/mark.png)
SERIAL NUMBER: 88070382
OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Astellas Institute for Regenerative Medicine, having an address of
33 Locke Drive
Marlborough, Massachusetts 01752
United States
Email: XXXX
Proposed: Astellas Institute for Regenerative Medicine, having an address of
33 Locke Drive
Marlborough, Massachusetts 01752
United States
Phone:
Fax:
Email: XXXX
The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 05/14/2019.
For International Class 001:
Current identification: Cells, cell extracts, components of cells and cell culture media for medical and scientific research
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
For International Class 005:
Current identification: Cells, cell extracts, components of cells and cell culture media for medical or clinical use for the treatment of a variety of human and animal diseases and conditions;
pharmaceutical products for the treatment of degenerative diseases and disorders, ophthalmic diseases and conditions, inflammation and inflammatory diseases and disorders, and diseases and disorders
of aging
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
For International Class 042:
Current identification: Biotechnology services, namely, medical and scientific research in the field of producing cell types, cell extracts, components of cells and cell culture media
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
This is the fourth extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension
request: product or service research or development
Correspondence Information (current):
Kathleen T. Gallagher-Duff
PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@cov.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): kgallagher-duff@cov.com
Correspondence Information (proposed):
Kathleen T. Gallagher-Duff
PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@cov.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): kgallagher-duff@cov.com
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all
official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $375 will be submitted with the form, representing payment for 3 classes.
Declaration
STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section
1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the
mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of
the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near
resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and
the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made
on information and belief are believed to be true.
Signature: /Christopher Bolinger/ Date Signed: 03/26/2021
Signatory's Name: Christopher Bolinger
Signatory's Position: Senior Director, IP Legal, Trademarks of Astellas US LLC
Signature method: Sent to third party for signature
PAYMENT: 88070382
PAYMENT DATE: 03/26/2021
Serial Number: 88070382
Internet Transmission Date: Fri Mar 26 13:38:39 ET 2021
TEAS Stamp: USPTO/ESU-XXX.XXX.XXX.XXX-20210326133839
113633-88070382-770b1ea8519a08e4e1d3823a
b5268fa13fc14ef8e3a9eaddf4ab6555da975b9b
9-DA-38372789-20210326100831058733